Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Biological rationales and clinical applications of temperature controlled hyperthermia–implications for multimodal cancer treatments
Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies
Heat shock proteins in glioblastomas
Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data
Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study
The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin
Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum
Tumor antigen presentation by dendritic cells
Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy
Towards a standardized protocol for the generation of monocyte-derived dendritic cell vaccines
Personalized dendritic cell-based tumor immunotherapy
Dendritic cell vaccines for brain tumors
Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results
Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification
Heat shock proteins and immunity: application of hyperthermia for immunomodulation
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer
Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma
Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors